U.S. FDA approves Pfizer's nasal spray for migraine
March 10 - The U.S. Food and Drug Administration on Friday approved Pfizer Inc's
nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches. The drug Zavzpret, also known as zavegepant, was approved for the treatment of acute migraine with or without aura in adults, the company said. Aura refers to any neurological disturbance that appears shortly before or during the development of migraines.
The drug, whose pricing will be revealed at launch in July, is "expected to be comparable in price to other FDA approved migraine medicines" which belong to the same class of drugs, the company told Reuters. Pfizer added Zavzpret and other migraine treatments, including Nurtec ODT, to it drugs portfolio through its $11.6 billion buyout of Biohaven PharmaceuticalZavzpret belongs to a class of drugs called calcitonin gene-related peptide inhibitors and will compete with other therapies from AbbVie Inc , Eli Lilly and Co
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer wins FDA approval for its migraine nasal sprayPfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
Weiterlesen »
FDA approves Pfizer's new nasal spray treatment for migrainesThe FDA approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant), the first and only migraine treatment offered in a nasal spray.
Weiterlesen »
North Texas Food Bank food distribution events this weekThe North Texas Food Bank is holding several walk-up and drive through food giveaways this week.
Weiterlesen »
Utah Food Bank expects increased demand as boost to food stamps endsThe Utah Food Bank is gearing up for more demand for assistance after boosted food stamp benefits ended in February.
Weiterlesen »
FDA Approves Amphastar Pharma's Nasal Spray for Opioid OverdoseAmphastar Pharmaceuticals Inc said on Wednesday the FDA had approved its nasal spray for emergency treatment of known or suspected opioid overdose.
Weiterlesen »
Albuterol Shortage Challenges Hospitals Treating Patients With Breathing ProblemsHospitals are running out of a liquid form of albuterol, a medication used to treat people with breathing problems, weeks after the only maker of the product declared bankruptcy
Weiterlesen »